IL6 and non-small cell lung carcinoma: 3.3 Clinical significance of plasma sIL-6R or sgp130 levels and the ratios of binary IL-6:sIL-6R and ternary IL-6:sIL-6R:sgp130 complexes in non-small cell lung cancer patients treated with ICIs